![]()
MIRA INFORM REPORT
|
Report Date : |
23.03.2011 |
IDENTIFICATION DETAILS
|
Name : |
AVALON PHARMA |
|
|
|
|
Registered Office : |
BP 5508 |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
14.04.2005 |
|
|
|
|
Legal Form : |
Limited Liability Company, Limited by shares |
|
|
|
|
Line of Business : |
Dealers in pharmaceuticals and related products |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
20,000 USD |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2010
|
Country Name |
Previous Rating (30.09.2010) |
Current Rating (31.12.2010) |
|
|
b2 |
b2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Currency of
Report: CFA
|
COMPANY
REPORTED: |
AVALON PHARMA |
|||
|
Principal Address: |
BP 5508 |
|||
|
Telephone: |
+221-33-9610241 |
|||
|
Fax: |
+221-33-9610241 |
|||
|
Email: |
None |
|||
|
Internet: |
None |
|||
|
Established: |
14/04/2005 |
|||
|
Registration: |
|
|||
|
Legal
Form: |
Limited
Liability Company, Limited by shares |
|||
|
Stock
Listing: |
Not
Listed |
|||
|
Workforce: |
2010 |
|
|
|
|
|
30 |
|
|
|
|
Office & Factories |
|
|||
|
Head
offices |
9
Eme Rue Laybar Sor, |
|||
|
Branches
|
None
|
|||
Current Credit Limit: 20,000 USD
Management/ Directors
|
President/ CEO (1) |
|
|
Name |
M Kishan |
|
Remarks |
Top
Decision Maker |
|
Director
(2) |
|
|
Name |
R Kumar |
̃ Top decision maker is the person who has the ultimate
authority or power to make important managerial decisions. He/She may or may
not be officially registered as a president or an executive director.
No negative
information found.
|
Company Profile: |
|
||
|
Nominal
Capital |
CFA. 50,000,000 |
||
|
Shareholders |
|
||
|
Name |
Position |
Amount |
Ratio |
|
M Kishan |
Director |
|
|
|
R Kumar |
Director |
|
|
|
Total
|
|
|
100.00% |
Terms of payment
Buying terms 30% in cash, 70% on credit
Selling terms 80% in cash, 20%
on credit
Recent Sales CFA. 600,000,000
(2010 Estimated)
Exports None
Export Ratio 0.0%
Import Ratio 40.0%
Domestic Market
Share 10.0%
|
Affiliated Companies |
None
|
No financial statement disclosed.
Business Activities Dealers in pharmaceuticals and related products
Suppliers Various Companies
Customers firms and
organizations
Business Premises 2000 Sft
Type of
occupation Owned
Location The subject is
located close to a major road network
Premises used
as Offices
Banking relationship
Main Banks Eco Bank
(as of report date)
Payment Morale: In the documents at our disposal nothing adverse has been shown so far.
CREDIT RATING: Financial situation is average.
Na
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.97 |
|
|
1 |
Rs.73.35 |
|
Euro |
1 |
Rs.63.98 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history (10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.